Author Affiliations: Departments of Medicine (Dr Lerner), Dermatology (Drs Beckford, Ugent, Goldberg, and Demierre), and Otolaryngology –Head and Neck Surgery (Dr Jalisi), Boston University School of Medicine, Boston, Massachusetts.
Malignant hidradenocarcinoma is a rare locally aggressive eccrine tumor with high metastatic potential.1 Few studies have reported effective therapy for this malignant neoplasm, and in none has a complete response been observed.2,3 We describe a patient with unresectable metastatic malignant hidradenocarcinoma who experienced a durable complete clinical and radiologic response after 3 months of oral capecitabine treatment.
Lerner A, Beckford A, Ugent S, Goldberg L, Jalisi S, Demierre M. Complete Response of Metastatic Malignant Hidradenocarcinoma to Capecitabine Treatment. Arch Dermatol. 2011;147(8):998–999. doi:10.1001/archdermatol.2011.210
Monkeypox Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.